Optimising positioning for infants born with Congenital Diaphragmatic Hernia

Congenital Diaphragmatic Hernia

Congenital diaphragmatic hernia (CDH) is a condition requiring immediate medical and multidisciplinary management, including physiotherapy. Positioning is a commonly used physiotherapy technique supported by the literature. However, the extent of its improvement on the respiratory system is unknown due to the limitations of the measuring equipment. Current measuring tools lack the ability to detect regional changes in the lungs. Electrical impedance tomography (EIT) has shown to be safe and effective in other areas of the healthcare system but has not been used for infants with CDH. This study will use EIT to assess the effectiveness of positioning in infants with CDH.

Category
Trial Status
Not yet recruiting
Trial Phase
Other
ERM Project ID
103705
Trial contact details
Contact Person
Dr Judith Hough
What you need to know

Who can take part?

The inclusion criteria allow for the largest number of participants available to be involved. The exclusion criteria, ensure that co-morbidities will interfere with the accuracy of the data and that infant care will remain the priority. 

Inclusion Criteria 

  • Infant's age less than or equal to 12 months 
  • CDH diagnosis
  • Parents/guardians given informed consent. 

Exclusion Criteria 

  • Infants with associated anomalies that would directly affect postnatal outcome. 
  • Infants with associated diseases or conditions compromising the cardiorespiratory system other than CDH. 
  • Infants with fragile skin conditions at risk of skin breakdown from the EIT belt. 

 

Parents will be given up to 24 hours to consider inclusion into the study.

What is involved for you? 

The research project will use different pieces of equipment to see how the air moves to different parts of the lungs when babies with CDH breath, and how this pattern is changed when placed in different positions.

Participating babies will be placed in different positions including on their stomach, on their back or on their side during the study period.  

Regular position changes are part of usual care for a baby with CDH and the baby's medical and nursing care will not be affected or changed by being involved in this research.
 

All research clinical trials news

2023 was an outstanding year for Mater Research with $13.7 million in grant funding received and 424 publications recorded.

29

Feb

Highlighting Mater Research’s year of achievements: 2023 Annual Report

When Monique Perry was diagnosed with aggressive triple-negative breast cancer she feared her family history was about to repeat itself.

27

Oct

Clinical trials give Queensland breast cancer patients hope

Mater researchers in Brisbane are leading a trial of a game-changing flu vaccine that has the potential to provide greater and more durable protection against the virus.

23

May

Mater launches trial of Australian-first flu vaccine

Displaying results 1-3 (of 18)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|